AV-513

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameAV-513

Drug Alias NameAV-513

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTissue factor pathway inhibitor inhibitors

TargetsTissue factor pathway inhibitor

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAvigen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAvigen Inc

Active IndicationsN/A

Inactive IndicationsHemophilia A

ATC CodeN/A